Introduction
It was reported that adenine causes fetal malformations with high frequency when 250 or 300 mkikg of the compound was injected I. p. (.intraperitoneally) to pregnant mice during major organogenesis (Fujii and Nishimura, 1970 Fujii, 1970) . Chaube and Murphy (1969) administered the compound i. R. to female rats on day 12 of gestation at various dosages less than 250 mg/kg, but did not find .any embryotoxic effect. In the present experiment, we injected -adenine at higher dosages to rats on various days of gestation to 'examine its potential teratogenicity and the spectrum of malformations.
Methods
Sprague Dawley rats, purchased from Japan CLEA Co. (Takatsuki, Osaka) at 4 weeks of age, were raised for about 6 weeks at N.M.B. Research Laboratories. During this period as well as throughout the experiment mentioned below, they were kept in an air-conditioned room at 22+1°C and 55+5% of humidity and fed solid chow for rats and mice (CA-1) purchased from Japan CLEA Co. (Meguro, Tokyo). Fresh water was allowed ad libitum. Nulliparous females of 10 to -13 weeks of age were mated overnight (17 hours) with adult males of the same strain. Copulation was established next morning by the presence of a vaginal plug and the day, when the plug was found, was designated as day 1 of gestation. The presumably pregnant rats were divided into 9 groups (A, B, C, B, E, F, G, H and I) and the 1) Adenine was manufactured by Sigma Chemical Company (St. Louis, U. S. A.) and obtained through Katayama Chemical Company (Osaka, Japan). 47 other two groups. At about 9AM on day 8 of gestation; the animals of group A were treated with a single i. p. injection of adenine at a dosage of 300 mg/kg. Similar treatment was made on day 9 for the animals of group B, day 10 for group C, day 11 for group D, day 12 for group E, day 13 for group F, day 14 for group G and day 15 for group H. Group I served as the control without any treatment.
Animals of the other two groups were treated with a single i. p. injection of the compound at a dosage of 350 mg/kg on day 10 or 14 of gestation to see a dose-effect relationship. Females were sacrificed on day 21 of gestation. The number of implantation sites and signs of death such as fetal resorption or maceration were checked in situ, and living fetuses were removed from the uterus, weighed and examined for external deformities including those in the oral cavity. They were then fixed either in Bouin's solution and preserved in saturated picric acid solution for examination of internal organs by razor blade sectioning (Wilson 1965) or in 95% alcohol for examination of skeletal malformations after cleared and stained with alizarin red S.
Results
Effect on the pregnant females : Treated females showed a twitching of abdominal muscles for several minutes after injection, followed by recovery. When autopsied on day 21 of gestation, all the treated females showed " frosted liver ", an evidence resulted from inflammatory response. Histological examination of several cases of the liver and kidney randomly selected revealed thickening of the capsula hepatis, hepatic edema and renal edema.
External observations of the fetus : The main results of external observation on the fetuses are listed in table 1. In group B and F, significantly high frequency of fetal resorption was shown. Significant growth suppression was shown in all the treatment groups. Various types of malformations were found in group C, E, F and G. The significant frequency was shown in group G.
Internal observation of the fetus : Table 2 summarizes the results of internal examination.
Number of deformed live fetuses was significantly increased in groups A, B, C, E and F. The types of malformations most frequently observed were hydrocephaly and hydronephrosis. Eye defects and esophagectopy were also found with significant frequency in group C and F respectively.
Skeletal observation of the fetus : Results and classification of malformations according to the site of them are listed in table 3. Significantly high frequency of the malformed fetuses was shown in In high dose groups, the types of malformations observed externally, internally or on the skeleton were similar to those found in respective low does groups.
Discussion
Toxic aspect of adenine injected i. p. to rats was studied by Philips et al. (1952) and Philips et al. (1954) . LD50 values of the i. p. injection in the rat obtained by both studies were 198 mg/kg and less than 300 mg/kg respectively. In this study, however, the injection of 300 or 350 mg/kg was well tolerated by pregnant females and no dead case was found, although inflammatory response in the liver and toxic change of the kidney of the female was observed.
As for the embryotoxicity, biphasic increase of toxic and teratogenic effects were shown in terms of fetal resorption, growth suppression and incidence of internal defects such as hydrocephaly and hydronephrosis. On the other hand, malformations of the eye were observed only in the group treated on day 10 of gestation.
In the mouse study (Fujii, 1970) , where 250 mg/kg of adenine was once injected i. p. on each day during major organogenesis, skeletal malformations were generally severer and a relation between the day of treatment and localization of the malformations was very clear. In the rat, however, such relation was less clear and digital itiaformations were found only in group treated on day 14. Side preponderance of the defects as shown in the mouse (Fujii and Nishimura, unpublished) , was not revealed in the rat. Philips et al. (1954) reported that a large dosage of adenine resulted in the formation of obstructive crystalline deposits in renal tubles. But other purine metabolites such as inosinate, hypoxanthine and guanosine, which do not form the crystalline deposits in renal tubles, were found to cause malformations of the similar types in the mouse (Fujii and Nishimura, unpublished) .
So, the maternal nephrotoxicity of adenine may not play an essential role in its teratogenicity.
It may be probable that some disturbance of purine metabolism in the embryonic tissues such as feed back mechanism for de novo synthesis of purine metabolites is linked to causation of malformations.
Summary
The pregnant female rats were treated i. p. with a single dose of adenine at 300 or 350 mg/kg once during major organogenesis of the embryo. Near-term fetuses were examined for external, internal and skeletal malformations and the followings were resulted.
(1) Fetal resorption was increased when 300 mg/kg of the compound was treated on day 9 or 14 of gestation.
(2) Body weight of live fetuses was lowered in all the groups treated at 300 mg/kg.
(3) The fetuses with digital malformations were found with significantly high frequency in group treated at 300 mg/kg on day 14 of gestation.
(4) Significantly high frequency of the fetuses with internal malformations was resulted by treatment at 300 mg/kg on day 8, 9, 10, 12 or 13 of gestation.
(5) Significantly high frequency of skeletal malformations was shown in all the treated groups except group treated on day 15 of gestation.
(6) With such indices as fetal resorption, body weight, external, internal and skeletal malformations, a dose effect relation was clearly shown in groups treated on day 10 or 14 of gestation.
(7) Less embryopathic effects of adenine was shown in the rats compared to the mice treated with its lower dosage.
